Another pharma megamerger: AbbVie buys Allergan for $63 billion

Erika Beras Jun 25, 2019
HTML EMBED:
COPY
PHILIPPE HUGUEN/AFP/Getty Images

Another pharma megamerger: AbbVie buys Allergan for $63 billion

Erika Beras Jun 25, 2019
PHILIPPE HUGUEN/AFP/Getty Images
HTML EMBED:
COPY

Earlier this year, Bristol-Myers Squibb announced it was buying Celgene for $74 billion. Now AbbVie, which makes popular drug Humira, has entered into an agreement to pay about $63 billion for Allergan, the manufacturer of Botox. What’s in it for both companies?

Click the audio player above to hear the full story.

As a nonprofit news organization, our future depends on listeners like you who believe in the power of public service journalism.

Your investment in Marketplace helps us remain paywall-free and ensures everyone has access to trustworthy, unbiased news and information, regardless of their ability to pay.

Donate today — in any amount — to become a Marketplace Investor. Now more than ever, your commitment makes a difference.